In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Compounded "semaglutide" is not FDA approved semaglutide.com The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law